Introduction: To address the poor water solubility and low bioavailability of the curcumin derivative CU1, this study constructed a long-circulating pH-sensitive nanoliposome (CU1-LCpHL) as its delivery system. Methods: The physicochemical properties, stability, and anti-lung cancer efficacy of CU1-LCpHL were systematically evaluated, including in vitro cellular assays (cellular uptake, apoptosis, proliferation, and migration), in vivo pharmacokinetics and pharmacodynamics, mechanistic studies, and immunohistochemical analysis. Results: CU1-LCpHL presented a spherical morphology with uniform particle size. Its lyophilized powder remained stable for at least three months at 25°C and exhibited sustained-release characteristics. In vitro experiments demonstrated that, compared to free curcumin (CU), free CU1, and long-circulating stable nanoliposomes (CU1-LSLN), CU1-LCpHL promoted more efficient cellular uptake, induced apoptosis, and significantly inhibited the proliferation and migration of lung cancer cells. Pharmacokinetic studies revealed that the area under the curve (AUC 0-t ) of CU1-LCpHL was 9.52-fold and 9.47-fold higher than that of CU and CU1, respectively, while its mean residence time (MRT 0-t ) was 3.37-fold and 7.69-fold longer, respectively. In vivo pharmacodynamic results indicated that the tumor-inhibition rate of CU1-LCpHL was 2.42-, 2.17-, and 1.37-fold higher than those of CU, CU1, and CU1-LSLN, respectively, with no significant organ toxicity or hemolysis observed. Mechanistic studies showed that CU1-LCpHL significantly upregulated Caspase-3, Caspase-9, and Bax, while downregulating the p-AKT/AKT ratio and Bcl-2 levels. Immunohistochemical analysis further confirmed that CU1-LCpHL markedly reduced the positive expression of Ki67, CD34, and VEGFR2, outperforming all other treatment groups. Conclusion: CU1-LCpHL significantly enhances the delivery efficiency and antitumor efficacy of CU1, representing a promising nano-drug delivery system for lung cancer therapy. Keywords: curcumin derivative, long-circulating pH-sensitive nanoliposomes, lung cancer efficacy, pharmacokinetics, mechanism
Building similarity graph...
Analyzing shared references across papers
Loading...
Yuqian Pu
Yongqiang Jiang
Xinya Li
International Journal of Nanomedicine
Southwest Medical University
Building similarity graph...
Analyzing shared references across papers
Loading...
Pu et al. (Sun,) studied this question.
www.synapsesocial.com/papers/69ba427c4e9516ffd37a2c23 — DOI: https://doi.org/10.2147/ijn.s588259